share_log

綠葉製藥:建議分拆博安生物並將其於聯交所主板獨立上市 - 合資格股東於優先發售中的保證配額基準

LUYE PHARMA: PROPOSED SPIN-OFF AND SEPARATE LISTING OF BOAN BIOTECH ON THE MAIN BOARD OF THE STOCK EXCHANGE - BASIS OF ASSURED ENTITLEMENT OF QUALIFYING SHAREHOLDERS IN THE PREFERENTIAL OFFERING

Dec 16, 2022 03:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more